Skip to main content
Article
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.
The New England journal of medicine
  • CODA Collaborative, CODA Collaborative
  • David R Flum
  • Giana H Davidson
  • Sarah E Monsell
  • Nathan I Shapiro
  • Stephen R Odom
  • Sabrina E Sanchez
  • F Thurston Drake
  • Katherine Fischkoff
  • Jeffrey Johnson
  • Joe H Patton
  • Heather Evans
  • Joseph Cuschieri
  • Amber K Sabbatini
  • Brett A Faine
  • Dionne A Skeete
  • Mike K Liang
  • Vance Sohn
  • Karen McGrane
  • Matthew E Kutcher
  • Bruce Chung, Maine Medical Center
  • Damien W Carter, Maine Medical Center
  • Patricia Ayoung-Chee
  • William Chiang
  • Amy Rushing
  • Steven Steinberg
  • Careen S Foster
  • Shaina M Schaetzel
  • Thea P Price
  • Katherine A Mandell
  • Lisa Ferrigno
  • Matthew Salzberg
  • Daniel A DeUgarte
  • Amy H Kaji
  • Gregory J Moran
  • Darin Saltzman
  • Hasan B Alam
  • Pauline K Park
  • Lillian S Kao
  • Callie M Thompson
  • Wesley H Self
  • Julianna T Yu
  • Abigail Wiebusch
  • Robert J Winchell
  • Sunday Clark
  • Anusha Krishnadasan
  • Erin Fannon
  • Danielle C Lavallee
  • Bryan A Comstock
  • Bonnie Bizzell
  • Patrick J Heagerty
  • Larry G Kessler
  • David A Talan
Document Type
Article
Publication Date
10-5-2020
Institution/Department
Trauma & Acute Care Surgery
Disciplines
MeSH Headings
Appendectomy, Appendicitis, Anti-Bacterial Agents, Metronidazole, Acute Disease
Abstract

BACKGROUND: Antibiotic therapy has been proposed as an alternative to surgery for the treatment of appendicitis.

METHODS: We conducted a pragmatic, nonblinded, noninferiority, randomized trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centers. The primary outcome was 30-day health status, as assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire (scores range from 0 to 1, with higher scores indicating better health status; noninferiority margin, 0.05 points). Secondary outcomes included appendectomy in the antibiotics group and complications through 90 days; analyses were prespecified in subgroups defined according to the presence or absence of an appendicolith.

RESULTS: In total, 1552 adults (414 with an appendicolith) underwent randomization; 776 were assigned to receive antibiotics (47% of whom were not hospitalized for the index treatment) and 776 to undergo appendectomy (96% of whom underwent a laparoscopic procedure). Antibiotics were noninferior to appendectomy on the basis of 30-day EQ-5D scores (mean difference, 0.01 points; 95% confidence interval [CI], -0.001 to 0.03). In the antibiotics group, 29% had undergone appendectomy by 90 days, including 41% of those with an appendicolith and 25% of those without an appendicolith. Complications were more common in the antibiotics group than in the appendectomy group (8.1 vs. 3.5 per 100 participants; rate ratio, 2.28; 95% CI, 1.30 to 3.98); the higher rate in the antibiotics group could be attributed to those with an appendicolith (20.2 vs. 3.6 per 100 participants; rate ratio, 5.69; 95% CI, 2.11 to 15.38) and not to those without an appendicolith (3.7 vs. 3.5 per 100 participants; rate ratio, 1.05; 95% CI, 0.45 to 2.43). The rate of serious adverse events was 4.0 per 100 participants in the antibiotics group and 3.0 per 100 participants in the appendectomy group (rate ratio, 1.29; 95% CI, 0.67 to 2.50).

CONCLUSIONS: For the treatment of appendicitis, antibiotics were noninferior to appendectomy on the basis of results of a standard health-status measure. In the antibiotics group, nearly 3 in 10 participants had undergone appendectomy by 90 days. Participants with an appendicolith were at a higher risk for appendectomy and for complications than those without an appendicolith. (Funded by the Patient-Centered Outcomes Research Institute; CODA ClinicalTrials.gov number, NCT02800785.).

Citation Information
CODA Collaborative, David R Flum, Giana H Davidson, Sarah E Monsell, et al.. "A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis." The New England journal of medicine (2020) ISSN: 1533-4406
Available at: http://works.bepress.com/damien-carter/17/